Cardioprotective Effects of Low-Dose Cyclosporin A Added to Histidine-Tryptophan-Ketoglutarate Cardioplegia Solution prior to Total Myocardial Ischemia: An in vitro Rabbit Heart Study
Authors:
- P. Pritzwald-StegmannPPP. Pritzwald-Stegmann
- A. HoyerAHA. Hoyer
- J. KempfertJKJ. Kempfert
- S. DheinSDS. Dhein
- F.W. MohrFMF.W. Mohr
- 22 September 2011
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 88 (3-4) , 167-173
Abstract
Background/Aims: Mitochondrial permeability transition pore (MPTP) opening appears to play a key role in myocardial cell survival after ischemia-reperfusion injury and can be inhibited by cyclosporin A (CsA). We investigated whether low-dose CsA added to histidine-tryptophan-ketoglutarate (HTK) cardioplegia solution could improve myocardial protection during longer periods of global myocardial ischemia as encountered during cardiac surgery. Methods: Rabbit hearts perfused on a Langendorff apparatus were arrested with cold HTK solution containing 1 µmol/l CsA. After 90 min of ischemia, the hearts were reperfused and pmax, max dp/dt, min dp/dt, myocardial stiffness, pO2, coronary flow and heart rate recorded. Tissue ATP and malondialdehyde (MDA) were measured to assess cell energy content and oxidative stress, respectively. Results: CsA-treated hearts recovered pmax (p = 0.026), max dp/dt (p = 0.028) and min dp/dt (p = 0.025) more quickly and to a greater extent than non-treated hearts. They required markedly less oxygen (p = 0.041) in the first 10 min of reperfusion. Hearts treated with CsA produced 44% less MDA (1.09 vs. 1.93, p = 0.008), while ATP levels were unchanged. Conclusions: HTK cardioplegia solution containing CsA at a dose well below that expected to cause systemic immunosuppressive effects leads to a significant and timelier recovery of myocardial contractility, while consuming less oxygen.Keywords
This publication has 32 references indexed in Scilit:
- Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondriaProceedings of the National Academy of Sciences, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- Is blood cardioplegia superior to crystalloid cardioplegia?Interactive CardioVascular and Thoracic Surgery, 2008
- Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition poreCardiovascular Research, 2007
- Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusionActa Anaesthesiologica Scandinavica, 2007
- Early Reperfusion PhenomenaSeminars in Cardiothoracic and Vascular Anesthesia, 2006
- Mitochondrial Permeability Transition Pore Opening as an Endpoint to Initiate Cell Death and as a Putative Target for CardioprotectionCellular Physiology and Biochemistry, 2006
- Ischaemic Preconditioning Inhibits Opening of Mitochondrial Permeability Transition Pores in the Reperfused Rat HeartThe Journal of Physiology, 2003
- Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic HeartThe Annals of Thoracic Surgery, 1997
- Clinical Effect of Bretschneider-HTK and St. Thomas Cardioplegia on Hemodynamic Performance after Bypass Measured using an Automatic Datalogging Database SystemThe Thoracic and Cardiovascular Surgeon, 1988